63 related articles for article (PubMed ID: 32723382)
21. Predictive Factors for Lateral Lymph Node Metastasis and Skip Metastasis in Papillary Thyroid Carcinoma.
Feng JW; Qin AC; Ye J; Pan H; Jiang Y; Qu Z
Endocr Pathol; 2020 Mar; 31(1):67-76. PubMed ID: 31828583
[TBL] [Abstract][Full Text] [Related]
22. Predicting skip metastasis in lateral lymph nodes of papillary thyroid carcinoma based on clinical and ultrasound features.
Zhao M; Shi X; Zou Z; Wen R; Lu Y; Li J; Cao J; Zhang B
Front Endocrinol (Lausanne); 2023; 14():1151505. PubMed ID: 37229457
[TBL] [Abstract][Full Text] [Related]
23. Risk Factors and a Prediction Model of Lateral Lymph Node Metastasis in CN0 Papillary Thyroid Carcinoma Patients With 1-2 Central Lymph Node Metastases.
Wang Y; Deng C; Shu X; Yu P; Wang H; Su X; Tan J
Front Endocrinol (Lausanne); 2021; 12():716728. PubMed ID: 34721289
[TBL] [Abstract][Full Text] [Related]
24. Lymph node characteristics of 6279 N1 differentiated thyroid cancer patients.
Sui C; He Q; Du R; Zhang D; Li F; Dionigi G; Liang N; Sun H
Endocr Connect; 2020 Jan; 9(3):201-10. PubMed ID: 31961797
[TBL] [Abstract][Full Text] [Related]
25. Investigating the Effect of Thyroid Nodule Location on the Risk of Thyroid Cancer.
Jasim S; Baranski TJ; Teefey SA; Middleton WD
Thyroid; 2020 Mar; 30(3):401-407. PubMed ID: 31910102
[No Abstract] [Full Text] [Related]
26. Risk Factors for and Prediction Model of Skip Metastasis to Lateral Lymph Nodes in Papillary Thyroid Carcinoma.
Hu D; Lin H; Zeng X; Wang T; Deng J; Su X
World J Surg; 2020 May; 44(5):1498-1505. PubMed ID: 31863139
[TBL] [Abstract][Full Text] [Related]
27. Lateral neck metastases in the ipsilateral and contralateral compartments of papillary thyroid carcinoma located in one lobe.
Kim SY; Kim SM; Chang H; Kim BW; Lee YS; Chang HS; Park CS
ANZ J Surg; 2019 Nov; 89(11):E498-E501. PubMed ID: 31566299
[TBL] [Abstract][Full Text] [Related]
28. Superior Located Papillary Thyroid Microcarcinoma is a Risk Factor for Lateral Lymph Node Metastasis.
Back K; Kim JS; Kim JH; Choe JH
Ann Surg Oncol; 2019 Nov; 26(12):3992-4001. PubMed ID: 31264121
[TBL] [Abstract][Full Text] [Related]
29. Risk factor analysis for predicting cervical lymph node metastasis in papillary thyroid carcinoma: a study of 966 patients.
Liu C; Xiao C; Chen J; Li X; Feng Z; Gao Q; Liu Z
BMC Cancer; 2019 Jun; 19(1):622. PubMed ID: 31238891
[TBL] [Abstract][Full Text] [Related]
30. The prognostic factors for clinical N1b patients in thyroid papillary carcinoma.
Yuksel UM; Turanli S; Acar Y; Berberoglu U
J Cancer Res Ther; 2019; 15(3):681-685. PubMed ID: 31169240
[TBL] [Abstract][Full Text] [Related]
31. Skip metastases to lateral cervical lymph nodes in differentiated thyroid cancer: a systematic review.
Attard A; Paladino NC; Lo Monte AI; Falco N; Melfa G; Rotolo G; Rizzuto S; Gulotta E; Salamone G; Bonventre S; Scerrino G; Cocorullo G
BMC Surg; 2019 Apr; 18(Suppl 1):112. PubMed ID: 31074393
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for skip metastasis and lateral lymph node metastasis of papillary thyroid cancer.
Zhao H; Huang T; Li H
Surgery; 2019 Jul; 166(1):55-60. PubMed ID: 30876667
[TBL] [Abstract][Full Text] [Related]
33. Possible prediction of patterns of cervical lymph node spread based on primary tumor location in papillary thyroid carcinomas.
Sancaktar ME; Saylam G; Öcal B; Uluat A; Bayır Ö; Çakal E; Korkmaz MH
Turk J Med Sci; 2019 Feb; 49(1):217-221. PubMed ID: 30761884
[TBL] [Abstract][Full Text] [Related]
34. [Report of cancer epidemiology in China, 2015].
Zheng RS; Sun KX; Zhang SW; Zeng HM; Zou XN; Chen R; Gu XY; Wei WW; He J
Zhonghua Zhong Liu Za Zhi; 2019 Jan; 41(1):19-28. PubMed ID: 30678413
[No Abstract] [Full Text] [Related]
35. NCCN Guidelines Insights: Thyroid Carcinoma, Version 2.2018.
Haddad RI; Nasr C; Bischoff L; Busaidy NL; Byrd D; Callender G; Dickson P; Duh QY; Ehya H; Goldner W; Haymart M; Hoh C; Hunt JP; Iagaru A; Kandeel F; Kopp P; Lamonica DM; McIver B; Raeburn CD; Ridge JA; Ringel MD; Scheri RP; Shah JP; Sippel R; Smallridge RC; Sturgeon C; Wang TN; Wirth LJ; Wong RJ; Johnson-Chilla A; Hoffmann KG; Gurski LA
J Natl Compr Canc Netw; 2018 Dec; 16(12):1429-1440. PubMed ID: 30545990
[TBL] [Abstract][Full Text] [Related]
36. THYROID NODULE LOCATION ON ULTRASONOGRAPHY AS A PREDICTOR OF MALIGNANCY.
Zhang F; Oluwo O; Castillo FB; Gangula P; Castillo M; Farag F; Zakaria S; Zahedi T
Endocr Pract; 2019 Feb; 25(2):131-137. PubMed ID: 30383496
[TBL] [Abstract][Full Text] [Related]
37. Predictive Factors of Lateral Lymph Node Metastasis in Papillary Thyroid Microcarcinoma.
Zhao W; Chen S; Hou X; Liao Q; Chen G; Zhao Y
Pathol Oncol Res; 2019 Jul; 25(3):1245-1251. PubMed ID: 30361912
[TBL] [Abstract][Full Text] [Related]
38. Pattern of and clinicopathologic risk factors for lateral lymph node metastases in papillary thyroid carcinoma patients with lateral cervical lymphadenopathy.
Gong Y; Yang J; Yan S; Su A; Liu F; Gong R; Zhu J; Li Z
Medicine (Baltimore); 2018 Sep; 97(36):e12263. PubMed ID: 30200164
[TBL] [Abstract][Full Text] [Related]
39. Clinical analysis of cervical lymph node metastasis risk factors in patients with papillary thyroid microcarcinoma.
Luo Y; Zhao Y; Chen K; Shen J; Shi J; Lu S; Lei J; Li Z; Luo D
J Endocrinol Invest; 2019 Feb; 42(2):227-236. PubMed ID: 29876836
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
